$0.3521
At close: May 22, 5:00 PM EST
REVIVA PHARMA HLDGS INC by Reviva Pharmaceuticals Holdings, Inc. (RVPH) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.51 | $-0.38 | $-1.04 | $-2.00 |
| Actual | $-0.19 | $-0.46 | $-0.57 | $-1.20 |
| Surprise | +62.7% | -21.1% | +45.5% | +40.0% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.33 | $-0.30 |
| Revenue | ||
| Consensus | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $-0.19 | $-0.51 | 62.7 % |
| Q1 | May 13, 2026 | $-0.46 | $-0.38 | -21.1 % |
| Q4 | Mar 30, 2026 | $-0.57 | $-1.04 | 45.5 % |
| Q3 | Nov 13, 2025 | $-1.20 | $-2.00 | 40.0 % |